1. GPCR/G Protein MAPK/ERK Pathway Stem Cell/Wnt Apoptosis
  2. Ras ERK Apoptosis
  3. KRASG12D-IN-7

KRASG12D-IN-7 是一种具有选择性的 KRASG12D 抑制剂。KRASG12D-IN-7 对 KRASG12D 在 GDP 和 GTP 结合状态下均显示出强结合活性,Kd 值分别为 1.12 nM 和 1.86 nM。KRASG12D-IN-7 抑制携带 KRASG12D 的 AsPC-1 细胞增殖,IC50 值为 10 nM,并抑制 MAPK 信号传导。KRASG12D-IN-7 在 AsPC-1 细胞中诱导 G0/G1 期阻滞和凋亡 (apoptosis),并强烈抑制其集落形成。KRASG12D-IN-7 可用于研究携带 KRASG12D 突变的癌症,特别是胰腺导管腺癌 (PDAC)。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

KRASG12D-IN-7

KRASG12D-IN-7 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 Ras 亚型特异性产品:

查看 ERK 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

KRASG12D-IN-7 is a selective KRASG12D inhibitor. KRASG12D-IN-7 displays strong binding activity for KRASG12D in both its GDP- and GTP- bound states, with Kd value of 1.12 nM and 1.86 nM, respectively. KRASG12D-IN-7 inhibits the proliferation of KRASG12D harboring AsPC-1 cells with an IC50 value of 10 nM and suppresses MAPK signaling. KRASG12D-IN-7 induces G0/G1 phase arrest and apoptosis in AsPC-1 cells, and strongly inhibits their colony formation. KRASG12D-IN-7 can be used for the study of cancers harboring KRASG12D mutation, particularly pancreatic ductal adenocarcinoma (PDAC)[1].

IC50 & Target[1]

KRas G12D

1.12 nM (Kd, GDP-bound states)

KRas G12D

1.86 nM (Kd, GTP-bound states)

体外研究
(In Vitro)

KRASG12D-IN-7 (Compound (R)-5a) (72 小时) 对携带 KRASG12D 突变的 AsPC-1 细胞 (IC50 = 10 nM)、GP2D 细胞 (IC50 = 2.7 nM)、AGS 细胞 (IC50 = 6.1 nM)、HPAF-II 细胞 (IC50 = 6.8 nM) 和 Ls513 细胞 (IC50 = 27.3 nM) 表现出强效且选择性的抗增殖活性,同时对其他 KRAS 突变体 (H358 G12C、G12S) 和 KRAS 野生型细胞系的抑制作用不显著 (IC50 > 1000 nM)[1]
KRASG12D-IN-7 可结合 GDP 和 GTP 结合形式的 KRASG12D,选择性地抑制 GDP 结合状态的 KRASG12D 与 SOS1 的相互作用,并阻碍 GTP 结合状态的 KRASG12D 与 RAF1 的结合[1]
KRASG12D-IN-7 (1-1000 nM,3 小时) 以剂量依赖方式降低 AsPC-1 细胞中 p-ERK 和 p-S6 的蛋白水平,有效抑制 KRAS 下游 MAPK 信号通路[1]
KRASG12D-IN-7 (1-1000 nM,24-72 小时) 在 AsPC-1 细胞中诱导 G0/G1 期阻滞和凋亡[1]
KRASG12D-IN-7 (5 nM,10 天) 强烈抑制 AsPC-1 细胞的集落形成[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: AsPC-1 cells
Concentration: 1, 10, 100, 1000 nM
Incubation Time: 3 h
Result: Reduced the protein levels of p-ERK and p-S6 in AsPC-1 cells.

Cell Cycle Analysis[1]

Cell Line: AsPC-1 cells
Concentration: 1, 10, 100, 1000 nM
Incubation Time: 24 h
Result: Increased G0/G1 phase cell proportion.
Downregulated CDK2/Cyclin D3 protein levels.

Apoptosis Analysis[1]

Cell Line: AsPC-1 cells
Concentration: 1, 10, 100, 1000 nM
Incubation Time: 72 h
Result: Induced apoptosis in AsPC-1 cells.
Increased Annexin V-positive cells.
Upregulated cPARP/cCasp-3 protein levels.
分子量

671.04

Formula

C31H32ClF2N7OSe

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
KRASG12D-IN-7
目录号:
HY-175529
需求量: